Abstract:The treatment of ischemic stroke (IS) remains a big challenge in clinics, and it is urgently needed to develop novel, safe, and effective medicines against IS. Here, we report the design, synthesis, and biological evaluation of organic NO2– donors as potential agents for the treatment of IS. The representative compound 4a was able to slowly generate low concentrations of NO2– by reaction with a thiol-containing nucleophile, and the NO2– was selectively converted into NO under ischemic/hypoxia conditions to protect primary rat neurons from oxygen–glucose deprivation and recovery (OGD/R)-induced cytotoxicity by enhancing the Nrf2 signaling and activating the NO/cGMP/PKG pathway. Treatment with 4a at 2 h before or after ischemia mitigated the ischemia/reperfusion-induced brain injury in middle cerebral artery occlusion (MCAO) rats by producing NO and enhancing Nrf2 signaling. Furthermore, 4a significantly promoted endothelial cell proliferation and angiogenesis within the ischemic penumbra. Our findings suggest that this type of NO2– donors, like 4a, may be valuable to fight IS and other ischemic diseases.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00282.The stability of 4a in different conditions; reaction kinetics of 4a and GSH; the pharmacokinetic behavior of 4a (including concentration–time curve and calculated pharmacokinetic parameters); the effects of 4a on enhancing Nrf2 signaling and activating the sGC/cGMP/PKG pathway in OGD/R rat primary cortical neurons, on blood pressure in rats, on enhancing the Nrf2 pathway in MCAO rats, and on the angiogenesis in vitro; the primers used in the real-time quantitative PCR; the HPLC analytical parameters of plasma NO2– levels and a representative chromatogram; HRMS spectra of the intermediates formed by the reaction of 4a with thiols; the 1H NMR, 13C NMR, and HRMS spectra for compounds 4a, 4c, and 4d; and the HPLC traces for the purity of compounds 4a–d (PDF)Molecular formula strings for compounds 4a–d (CSV)This article has not yet been cited by other publications.

O2-sulfonylethyl Protected Isopropylamine Diazen-1-ium-1,2-diolates As Nitroxyl (HNO) Donors: Synthesis, Β-Elimination Fragmentation, HNO Release, Positive Inotropic Properties, and Blood Pressure Lowering Studies.

Gabor Filters Based Segmentation For Monaural Sound Segregation

An Orthoformate-Bridged Bis-diazeniumdiolates: Enhanced Nitric Oxide Loading and Released NO under Physiological Conditions

[Design, Synthesis and Antiasthmatic Activities of NO-donating Seratrodast Derivatives].

Liquid nitric oxide donor for adjuvant therapy of acute ischemic stroke via nasal administration

Design, Synthesis, and Biological Evaluation of Organic Nitrite (NO 2 – ) Donors as Potential Anticerebral Ischemia Agents

Nitric Oxide (No)-Releasing Macromolecules: Rational Design and Biomedical Applications

Nitric Oxide Regulation of Myocardial O-2 Consumption and Hep Metabolism

Synthesis and nitroxyl (HNO) donating properties of benzoxadiazole-based Piloty's acids

Carnosine analogues containing NO-donor substructures: synthesis, physico-chemical characterization and preliminary pharmacological profile

Development of novel nitric oxide production inhibitors based on the 7H-pyrrolo[2,3-d]pyrimidine scaffold

Recent Advancements in Polymeric N-Nitrosamine-Based Nitric Oxide (NO) Donors and their Therapeutic Applications

Design, Synthesis, and Antisickling Investigation of a Nitric Oxide-Releasing Prodrug of 5HMF for the Treatment of Sickle Cell Disease

A Comparative Investigation of the Pulmonary Vasodilating Effects of Inhaled NO Gas Therapy and Inhalation of a New Drug Formulation Containing a NO Donor Metabolite (SIN-1A)

S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications

On-Demand Nitric Oxide Generation via Thermal Decomposition of N-Trityl Dihydro-1,2-Oxazines

Static and dynamic under-frequency load shedding: a comparison

Synthesis and Modeling Studies of Furoxan Coupled Spiro-Isoquinolino Piperidine Derivatives as NO Releasing PDE 5 Inhibitors

Detection of Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in dogs in the Czech Republic.

Peroxynitrite-Scavenging Organosilica Nanomedicines for Light-Controllable NO Release and Precision On-Demand Glaucoma Therapy

Advanced Nitric Oxide Generating Nanomedicine for Therapeutic Applications